Keeler Thomas Management LLC Makes New $797,000 Investment in HCA Healthcare, Inc. (NYSE:HCA)

Keeler Thomas Management LLC acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 2,652 shares of the company’s stock, valued at approximately $797,000.

Other institutional investors have also made changes to their positions in the company. Legacy Investment Solutions LLC acquired a new position in HCA Healthcare in the 3rd quarter valued at about $39,000. Capital Performance Advisors LLP bought a new position in HCA Healthcare during the 3rd quarter worth $41,000. Canoe Financial LP acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at approximately $41,000. Activest Wealth Management increased its stake in shares of HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after purchasing an additional 125 shares during the last quarter. Finally, Pinnacle Bancorp Inc. boosted its stake in HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after buying an additional 50 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.60% of the stock is currently owned by corporate insiders.

HCA Healthcare Stock Performance

NYSE HCA opened at $319.33 on Tuesday. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The firm has a market cap of $79.30 billion, a price-to-earnings ratio of 14.53, a PEG ratio of 1.10 and a beta of 1.64. The company has a fifty day moving average price of $313.72 and a 200-day moving average price of $350.53. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the company posted $5.90 EPS. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a $0.72 dividend. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.90%. The ex-dividend date is Monday, March 17th. HCA Healthcare’s payout ratio is 13.11%.

Analyst Ratings Changes

A number of research firms have recently weighed in on HCA. JPMorgan Chase & Co. restated a “neutral” rating and issued a $380.00 price target on shares of HCA Healthcare in a research note on Tuesday, December 17th. Barclays decreased their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research note on Monday, January 27th. Oppenheimer raised their price objective on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a report on Monday, October 28th. Wells Fargo & Company lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their price target for the stock from $400.00 to $320.00 in a report on Monday, November 25th. Finally, Raymond James cut HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.